Pricing Log in Create free account

Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) vs Better Therapeutics, Inc. (BTTX)

Biodexa Pharmaceuticals PLC Unsponsored ADR and Better Therapeutics, Inc. are both Biotechnology companies. Better Therapeutics, Inc. is the larger, with a market value of $850.0K against $440.0K — 1.9× the size. Better Therapeutics, Inc. has the higher net margin (0.00% vs −1,155.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 8 metrics below, Better Therapeutics, Inc. leads on 5 and Biodexa Pharmaceuticals PLC Unsponsored ADR on 3.

Valuation

Metric BDRX BTTX Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.20 n/m 0.64
EV/Sales (2.81) n/m 9.21
Earnings yield (555.04%) 0.00% (33.15%)
Free cash flow yield 0.00% 0.00% (25.50%)

Profitability

Metric BDRX BTTX Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin (1,155.70%) 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% 2,351.81% (56.36%)
Return on assets 0.00% (162.15%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BDRX BTTX Biotechnology median
Revenue growth (TTM) 60.22% — 6.02%
EPS growth (last fiscal year) 89.68% 45.66% 30.26%
Revenue growth, 5-year CAGR (28.78%) — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric BDRX BTTX Biotechnology median
Debt to equity 0.00 (1.44) 0.00
Current ratio 2.41 0.57 4.72
Net debt to EBITDA 1.00 0.02 0.96

Dividend

Metric BDRX BTTX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BDRX BTTX Biotechnology median
Market cap 440.00k 850.00k 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack